From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

BAA – Innovations to Help Ebola Healthcare Workers

by Global Biodefense Staff
October 10, 2014

The United States Agency for International Development (USAID) has issued a Broad Agency Announcement (BAA) seeking opportunities to co-create, co-design, co-invest, and collaborate in the development, testing, and scaling of practical and cost-effective innovations that can help healthcare workers on the front lines provide better care and stop the spread of Ebola.

In light of the persistence of the outbreak and the demands it has placed on global infection containment resources and processes, the federal disaster response community has recognized an opportunity to use open innovation to make significant strides in advancing our ability to combat Ebola.

Every day, in extreme heat and humidity, health care workers in Ebola-affected countries are performing life-saving tasks to prevent the spread of the virus. On the front lines of the Ebola epidemic, health care workers face many obstacles in providing the timely care to patients that is required to prevent the virus from spreading—from heat stress caused by the personal protective equipment (PPE) they wear, to lengthy infection control measures that leave no room for error, to communities reluctant to seek care.

Solutions are sought that work to strengthen healthcare capacities and improve care-seeking in the following areas:

  • Developing, testing, and scaling entirely novel PPE or modifications to current PPE that address issues of heat stress and comfort for healthcare workers
  • Accelerating the development and scale-up of approaches to enhance the physical and procedural care environment relating to heat stress, comfort and the safety of healthcare workers and patients
  • Accelerating the development and scale of tools that improve the delivery of care to patients (e.g. rapid, point of care diagnostics or more efficient ways of moving samples and communicating results back to health care workers quickly)
  • Developing and scaling behavior change approaches to encourage—and dispel myths and misconceptions that discourage—care-seeking or interacting with health care authorities
  • Improved information management and communication to the community on availability of beds in community care centers or emergency treatment facilities
  • Solutions (new or modified PPE kit or other innovative solutions) that allow much longer work periods, use less PPE, require fewer removals, generate less infectious waste and offer enhanced protection
  • New innovative barrier materials (e.g., antimicrobial treatments, nano-fibers, novel polymers and coatings, new finishing technologies, application of plasma processing and special reinforcements, using new nonwoven fiber bonding technologies, breathable membranes, etc.) that allow the same level of protection provided by the PPE today, but with higher levels of air and water vapor permeability, and breathability
  • PPE that is fully reusable
  • Low cost, next generation sensor technologies to seamlessly assess heat stress noninvasively when wearing PPE, including possible integration into the PPE to provide real-time monitoring and decision making on PPE use.
  • Modified PPE for use in non-health care settings (e.g. airport or security checkpoint screening, burials, etc.)
  • Portable personal cooling technologies that can be integrated into or compatible with existing PPE ensembles that are suitable for resource limited environments
  • Inexpensive, easily cleanable, and integrated powered air purifying respirators equipped with a hood or faceshield that can provide multi-functional protection (facial barrier protection and respiratory protection), while simultaneously cooling the facial region

This funding mechanism will not support research that does not provide a clear path to development and testing of prevention and intervention strategies. Awards are planned to be in the range of $100,000 to $1M.

The BAA is being executed in partnership with the White House Office of Science and Technology Policy, Centers for Disease Control, and the Department of Defense.

Further details are available under Solicitation Number: BAA-EBOLA-2014.

From Our Partners
Tags: AntimicrobialsBAABiosafetyEbolaEmerging ThreatsPOC Diagnostics

Related Posts

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC